drugset / Trial / NCT00942617

Measurement of Platelet Dense Granule Release in Healthy Volunteers

NCT00942617

NaSingle-groupOpen-labelBasic science

Summary

Aspirin has been shown to reduce cardiovascular events in at risk individuals. Elucidation of mechanisms of aspirin resistance and a possible loss of effect of aspirin over time with chronic aspirin treatment necessitate a more precise method of measuring the "release phase" of platelet activation, including the release of dense granules from platelets.

Timeline

Start
2009-07
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 40 mg